featured
Durable Remissions Following Combined Targeted Therapy in Patients With CLL Harboring TP53 Deletions and/or Mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Durable Remissions Following Combined Targeted Therapy in Patients With CLL Harboring TP53 Deletions and/or Mutations
Blood 2021 Jun 04;[EPub Ahead of Print], P Cramer, E Tausch, J von Tresckow, A Giza, S Robrecht, C Schneider, M Fürstenau, P Langerbeins, O Al-Sawaf, BW Pelzer, AM Fink, K Fischer, CM Wendtner, B Eichhorst, M Kneba, S Stilgenbauer, M HallekFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.